15 results
20-F/A
2018 FY
CMMB
Chemomab Therapeutics Ltd
24 Apr 19
Annual report (foreign) (amended)
5:19pm
We rely on a limited number of third parties for the supply of plasmids and other key raw materials required for our research and development … in distributor relationships, acquisitions or expansion plans;
changes in the prices of our raw materials or the products we sell;
our involvement
424B4
CMMB
Chemomab Therapeutics Ltd
13 Feb 19
Prospectus supplement with pricing info
8:20am
for the supply of plasmids and other key raw materials required for our research and development activities. If we are unable to reach agreements … relationships, acquisitions or expansion plans;
changes in the prices of our raw materials or the products we sell;
our involvement in litigation;
our sale
F-1/A
CMMB
Chemomab Therapeutics Ltd
11 Feb 19
Registration statement (foreign) (amended)
9:52am
for the supply of plasmids and other key raw materials required for our research and development activities. If we are unable to reach agreements … of our raw materials or the products we sell;
our involvement in litigation;
our sale of ADSs, ordinary shares or other securities in the future
F-1/A
wq1bsi tdj5y1dywwg
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.3
984vckvacc 239yctt2
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
3jtc984bj1wte7dv7
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
59d027n4kqsvfj9x2d
7 Jan 19
Registration statement (foreign)
5:11pm
DRS/A
gej1rtoxd3f60gnk073
27 Nov 18
Draft registration statement (amended)
12:00am
DRS
ly4jjv0
28 Sep 18
Draft registration statement
12:00am
20-F
n4ci3p331xpfvlyism
23 Apr 13
Annual report (foreign)
12:00am
424B3
20ycbdhssl2ws5 qde
7 Jun 12
Prospectus supplement
12:00am
F-4/A
vebdmb1707m9a0h5hxs6
5 Jun 12
Registration of securities (foreign) (amended)
12:00am
F-4
9ttm0
24 Jan 12
Registration of securities (foreign)
12:00am
- Prev
- 1
- Next